Brand Reference: BuSpar
| Metric | Verified Benchmark | Source |
|---|---|---|
| Buspirone Hydrochloride RxNorm Concept ID | 1827 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0420 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $31.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $5.30 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $6.80 / mo | 34 Zero-PHI Verified Patient Logs |
Acts as a full presynaptic somatodendritic 5-HT1A autoreceptor agonist in the dorsal raphe and partial postsynaptic hippocampal/cortical 5-HT1A agonist (with zero GABA-A binding)—relieving cognitive generalized worry and reversing SSRI sexual side effects with zero dependence or withdrawal.
Across 34 community cost disclosures for Buspirone Hydrochloride (BuSpar), cash buyers routing around $31.00 retail markups capture a 83% discount ($5.30/mo benchmark vs $0.0420 NADAC acquisition).
Following administration (7.5 mg PO BID), Buspirone Hydrochloride achieves ~4% absolute after extensive CYP3A4 first-pass (food doubles AUC; keep consistent) bioavailability and 2–4 weeks progressive receptor desensitization (not prn) onset, governed by a 2.5 hours terminal half-life through intestinal/hepatic cyp3a4 to active 1-pyrimidinylpiperazine (1-pp).
Before initiating Buspirone Hydrochloride at 7.5 mg PO BID, clinical safety checklists rule out maoi co-administration (hypertensive reaction); grapefruit juice excess. Logged tolerability patterns center on 30-minute post-dose lightheadedness/zaps (22% of reports), headache (9% of reports).
Across 34 verified cash-pay logs, Buspirone Hydrochloride achieves a 81.10% Worth-It rating with out-of-pocket spend averaging $6.80/mo versus $31.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 7.5 mg PO BID for Buspirone Hydrochloride; monthly out-of-pocket dropped to $4.66 compared with $31.00 retail.
Completed 10 weeks on Buspirone Hydrochloride (10 mg PO TID). Zero notable side effects on steady dosing.
Consistent biomarker response on 15 mg PO BID Buspirone Hydrochloride sourced via Local Pharmacy ($6.15/mo cash pay without insurance prior authorization).